Clinical Aspects of Gastrointestinal Food Allergy in Childhood
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Onset of Clinical Manifestations in Inflammatory Bowel Disease Patients
AG-2018-65 ORIGINAL ARTICLE dx.doi.org/10.1590/S0004-2803.201800000-73 The onset of clinical manifestations in inflammatory bowel disease patients Viviane Gomes NÓBREGA1, Isaac Neri de Novais SILVA1, Beatriz Silva BRITO1, Juliana SILVA1, Maria Carolina Martins da SILVA1 and Genoile Oliveira SANTANA2,3 Received 29/10/2017 Accepted 10/8/2018 ABSTRACT – Background – The diagnosis of inflammatory bowel disease is often delayed because of the lack of an ability to recognize its major clinical manifestations. Objective – Our study aimed to describe the onset of clinical manifestations in inflammatory bowel disease patients. Methods – A cross-sec- tional study. Investigators obtained data from interviews and the medical records of inflammatory bowel disease patients from a reference centre located in Brazil. Results – A total of 306 patients were included. The mean time between onset of symptoms and diagnosis was 28 months for Crohn’s disease and 19 months for ulcerative colitis. The main clinical manifestations in Crohn’s disease patients were weight loss, abdominal pain, diarrhoea and asthenia. The most relevant symptoms in ulcerative colitis patients were blood in the stool, faecal urgency, diarrhoea, mucus in the stool, weight loss, abdominal pain and asthenia. It was observed that weight loss, abdominal pain and distension, asthenia, appetite loss, anaemia, insomnia, fever, nausea, perianal disease, extraintestinal manifestation, oral thrush, vomiting and abdominal mass were more frequent in Crohn’s patients than in ulcerative colitis patients. The frequencies of urgency, faecal incontinence, faeces with mucus and blood, tenesmus and constipation were higher in ulcerative colitis patients than in Crohn’s disease patients. -
Insurance Coverage of Medical Foods for Treatment of Inherited Metabolic Disorders
ORIGINAL RESEARCH ARTICLE © American College of Medical Genetics and Genomics Open Insurance coverage of medical foods for treatment of inherited metabolic disorders Susan A. Berry, MD1, Mary Kay Kenney, PhD2, Katharine B. Harris, MBA3, Rani H. Singh, PhD, RD4, Cynthia A. Cameron, PhD5, Jennifer N. Kraszewski, MPH6, Jill Levy-Fisch, BA7, Jill F. Shuger, ScM8, Carol L. Greene, MD9, Michele A. Lloyd-Puryear, MD, PhD10 and Coleen A. Boyle, PhD, MS11 Purpose: Treatment of inherited metabolic disorders is accomplished pocket” for all types of products. Uncovered spending was reported by use of specialized diets employing medical foods and medically for 11% of families purchasing medical foods, 26% purchasing necessary supplements. Families seeking insurance coverage for these supplements, 33% of those needing medical feeding supplies, and products express concern that coverage is often limited; the extent of 59% of families requiring modified low-protein foods. Forty-two this challenge is not well defined. percent of families using modified low-protein foods and 21% of families using medical foods reported additional treatment-related Methods: To learn about limitations in insurance coverage, parents expenses of $100 or more per month for these products. of 305 children with inherited metabolic disorders completed a paper survey providing information about their use of medical foods, mod- Conclusion: Costs of medical foods used to treat inherited meta- ified low-protein foods, prescribed dietary supplements, and medical bolic disorders are not completely covered by insurance or other feeding equipment and supplies for treatment of their child’s disorder resources. as well as details about payment sources for these products. -
Ulcerative Proctitis
Patient & Family Guide 2016 Ulcerative Proctitis www.nshealth.ca Ulcerative Proctitis What is Inflammatory Bowel Disease? Inflammatory bowel disease (IBD) is the general name for diseases that cause inflammation (swelling and irritation) in the intestines (“gut”). It includes the following: • Ulcerative proctitis • Crohn’s disease • Ulcerative colitis What are your questions? Please ask. We are here to help you. 1 What is ulcerative proctitis and how is it different from ulcerative colitis? Ulcerative proctitis (UP) is a type of ulcerative colitis (UC). UC is an inflammatory disease of the colon (large intestine or large bowel). The inner lining of the colon becomes inflamed and has ulcerations (sores). The entire large bowel is involved in UC. When only the lowest part of the colon is involved (the rectum, 15 to 20 cm from the anus), it is called ulcerative proctitis. 15-20 cm Rectum Large intestine (large bowel) 2 How is ulcerative proctitis diagnosed? • A test called a sigmoidoscopy will tell us if you have this problem. The doctor uses a special tube which bends and has a small light and camera on the end to look at the inside of your lower bowel and rectum. The tube is passed through the anus to the rectum and into the last 25 cm of the large bowel. • A biopsy (small piece of bowel tissue is taken) during the test and sent to the lab for study. • Most people do not find the test and biopsy uncomfortable and medicine to relax or make you sleepy is not usually needed. What are the symptoms of ulcerative proctitis? • Rectal bleeding and itching, passing mucus through the rectum, and feeling like you always need to pass stool (poop) even though your bowel is empty. -
Ulcerative Proctitis
Ulcerative Proctitis Ulcerative proctitis is a mild form of ulcerative colitis, a ulcerative proctitis are not at any greater risk for developing chronic inflammatory bowel disease (IBD) consisting of fine colorectal cancer than those without the disease. ulcerations in the inner mucosal lining of the large intestine that do not penetrate the bowel muscle wall. In this form of colitis, Diagnosis the inflammation begins at the rectum, and spreads no more Typically, the physician makes a diagnosis of ulcerative than about 20cm (~8″) into the colon. About 25-30% of people proctitis after taking the patient’s history, doing a general diagnosed with ulcerative colitis actually have this form of the examination, and performing a standard sigmoidoscopy. A disease. sigmoidoscope is an instrument with a tiny light and camera, The cause of ulcerative proctitis is undetermined but there inserted via the anus, which allows the physician to view the is considerable research evidence to suggest that interactions bowel lining. Small biopsies taken during the sigmoidoscopy between environmental factors, intestinal flora, immune may help rule out other possible causes of rectal inflammation. dysregulation, and genetic predisposition are responsible. It is Stool cultures may also aid in the diagnosis. X-rays are not unclear why the inflammation is limited to the rectum. There is a generally required, although at times they may be necessary to slightly increased risk for those who have a family member with assess the small intestine or other parts of the colon. the condition. Although there is a range of treatments to help ease symptoms Management and induce remission, there is no cure. -
Progress Report Intestinal Malabsorption and the Skin
Gut: first published as 10.1136/gut.12.11.938 on 1 November 1971. Downloaded from Gut, 1971, 12, 938-947 Progress report Intestinal malabsorption and the skin The interrelationship between the gut and the skin is complex. It is certainly not a one-way system, and just as the gut can affect the skin so can the skin affect the gut: in fact there are four ways in which diseases of the skin and gut can be interrelated1' 2, namely, (1) malabsorption can cause a rash; (2) a rash can cause malabsorption; (3) skin abnormalities and malabsorption can have a common cause; and (4) skin disease and malabsorption can be related indirectly. Group I In this instance the rash arises as the result of malabsorption and disappears when the malabsorption is corrected. The concept was first formulated by William Hillary in 17593 and the idea was kept alive by Whitfield and his 'dermatitis colonica'.4 The early literature on the subject has been reviewed by Wells.5 Two groups ofphysicians6" 7 have looked at the incidence of rashes in adults with malabsorption and have quoted figures of 20%6 and 10%7 respectively. Conversely, in our dermatology department we have screened http://gut.bmj.com/ over 200 patients with the appropriate rashes (see below) and have not found clinical coeliac disease to be responsible for any of them. We have in the last seven years seen two patients with rashes secondary to coeliac disease but these had bowel symptoms as well as a rash at the time they presented to us. -
Diagnostic Errors in Referrals To
DIAGNOSTIC ERRORS IN REFERRALS TO THE ZAGREB FEVER HOSPITAL VLADIMIR GRAHOVAC Dr med., Head, general practice unit, Gajevo-Jarun and BOZIDAR GAVAZZI Dr med., Head, general practice unit, Savska Cesta Health Centre "Tresnjevka", Zagreb Errare humanum, corrigere philosophicum est THE MOST sensitive indicators are those relating to the quality of work. There are many indices of various degrees of objec- tivity for the evaluation of the quality of the doctor's work. One of them concerning hospital physicians is the degree of agreement between clinical diagnosis and postmortem findings 1. A similar indicator for non-hospital doctors is the degree ofagreement between their referral diagnosis and hospital discharge diagnoses. Since in Yugoslavia there are a great many contradictory opinions of the quality of work of doctors in general, and general practitioners in particular, and since they are often based on impressions and emotions rather than on objective studies, we decided to analyse the degree of agreement between referral diagnoses of the cases sent to the Zagreb fever hospital (hospital for contagious diseases) and the discharge diagnoses of this hospital. Although aware of defi- ciencies of this kind of study which relates only to a single hospital, and a specialized one at that, we decided to use it for the following reasons: 1. The fever hospital is one of the hospitals in which most case histories, in addition to referral diagnoses, contain the name of the physician who referred the patient to the hospital. This makes the subsequent identification possible. 2. Patients are for the most part sent to the fever hospital directly, without any preceding consultation with another doctor specialist or laboratory analysis. -
Robust Regression Analysis of GCMS Data Reveals Differential Rewiring of Metabolic Networks in Hepatitis B and C Patients
Article Robust Regression Analysis of GCMS Data Reveals Differential Rewiring of Metabolic Networks in Hepatitis B and C Patients Cedric Simillion 1,2, Nasser Semmo 2,3, Jeffrey R. Idle 2,3,4, and Diren Beyoğlu 2,4,* 1 Interfaculty Bioinformatics Unit and SIB Swiss Institute of Bioinformatics, University of Bern, Baltzerstrasse 6, 3012 Bern, Switzerland; [email protected] 2 Department of BioMedical Research, University of Bern, Murtenstrasse 35, 3008 Bern, Switzerland; [email protected] (N.S.); [email protected] (J.R.I.) 3 Department of Visceral Surgery and Medicine, Department of Hepatology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland 4 Division of Systems Pharmacology and Pharmacogenomics, Samuel J. and Joan B. Williamson Institute, Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, 11201 New York, NY, USA * Correspondence: [email protected]; Tel.: +41-31-632-87-11 Received: 11 September 2017; Accepted: 5 October 2017; Published: 8 October 2017 Abstract: About one in 15 of the world’s population is chronically infected with either hepatitis virus B (HBV) or C (HCV), with enormous public health consequences. The metabolic alterations caused by these infections have never been directly compared and contrasted. We investigated groups of HBV-positive, HCV-positive, and uninfected healthy controls using gas chromatography-mass spectrometry analyses of their plasma and urine. A robust regression analysis of the metabolite data was conducted to reveal correlations between metabolite pairs. Ten metabolite correlations appeared for HBV plasma and urine, with 18 for HCV plasma and urine, none of which were present in the controls. -
ROTAVIRAL INFECTION Simple Choice Multiple Choice
ROTAVIRAL INFECTION Simple choice 1. Choose the most receptive age for rotavirus infection: A. Newborns B. Children after 5 years C. Children 6-36 months D. Adults E. Elderly people 2. Select the causative agent that commonly cause viral diarrhea in children: A. Enterovirus B. Herpesvirus C. Coronavirus D. Astrovirus E. Rotavirus 3. Specify the character of the stool in the case of rotavirus infection in children: A. Frequent, poor, with mucus and blood, false calls and tenesmus, B. Liquid, frequent, light, greenish, mucous C. Frequent, aqueous, light, undigested, golden yellow or whitish D. Sanguinolent (with liquid blood), hemolytic-uremic syndrome, toxic shock E. Liquid stools, abdominal pain, followed by asymmetric and hypotonic flaccid paralysis. 4. Choose the etiological diagnosis of rotavirus infection: A. Lumbar puncture B. Biochemical blood test C. Blood culture D. Detection of rotavirus antigen in faces by ELISA E. Collecting the anamnestic of the disease and the objective examination thoroughly 5. Choose the basic treatment of Rotavirus infection in children: A. Antibacterial drugs B. Oral Rehydration C. Probiotics with high content of lacto and bifidobacteria D. Spasmolytics E. Corticosteroids Multiple choice 1. Indicate the main pathogenic mechanisms for rotavirus infection: A. Ulcerative and fibrinous necrotic inflammation in the submucosal and muscular layers of the large intestine B. Disaccharides deficiency C. Disruption of ideal water transport, sodium, and absorption abatement D. Fibrous inflammation of the large intestine mucosa E. Destruction of small intestine epitheliocytes 2. Choose the clinical signs characteristic of rotavirus infection in children: A. Confluent macula-papular rash spread throughout the body B. Acute debut with fever, vomiting, moderate, permanent periumbilical abdominal pain C. -
Oral Allergy Syndrome (OAS)
Oral Allergy Syndrome (OAS) The itchy, watery eyes, or that sudden tingling, itching or burning sensation in your mouth is all too familiar: it must be ragweed season again! After your soccer game, the juicy watermelon you share with a friend makes your mouth itchy, and you decide that maybe next time you will have to pass on the watermelon. But this is strange: you knew you were allergic to ragweed, but your reaction to watermelon is brand new. Although there is still so much we do not know about allergies, we do know that certain types of foods, or pollen like ragweed, are common culprits when it comes to giving the body an allergic reaction. Allergic reactions happen when a person’s immune system recognizes certain proteins called allergens, as foreign or unsafe. The body’s immune system then triggers an allergic response, like the swelling in your tongue and lips, to fight off the allergen. Oral Allergy Syndrome Some allergies can be much more complex, even downright sneaky. Oral Allergy Syndrome (OAS) is one such allergy. Certain types of fruits, vegetables, and nuts can trigger OAS, but you can also develop OAS even if you were not previously allergic to any of these foods. OAS only occurs in people who have pollen allergies. It is caused by allergens in fruit, vegetables and nuts that are very similar to allergens in pollen. Most only experience oral symptoms, but about 10% can experience nausea or stomach upset, and less than 5% will develop more serious whole-body allergic reactions, such as generalized hives, trouble breathing, or loss of consciousness. -
Adverse Reactions to Foods 2003
AAAAI Work Group Reports Work Group Reports of the AAAAI provide further comment or clarification on appropriate methods of treatment or care. They may be created by committees or work groups, and the end goal is to aid practitioners in making patient decisions. They do not constitute official statements of the AAAAI but serve to bring attention to key clinical or even controversial issues. They contain a bibliography, but typically not one as extensive as that contained within a Position Statement. AAAAI Work Group Report: Current Approach to the Diagnosis and Management of Adverse Reactions to Foods October 2003 The statement below is not to be construed as dictating an exclusive course of action nor is it intended to replace the medical judgment of healthcare professionals. The unique circumstances of individual patients and environments are to be taken into account in any diagnosis and treatment plan. This statement reflects clinical and scientific advances as of the date of publication and is subject to change. Prepared by the AAAAI Adverse Reactions to Foods Committee (Scott H. Sicherer, M.D., Chair and Suzanne Teuber, M.D., Co-Chair) Purpose: To provide a brief overview of the diagnosis and management of adverse reactions to foods. Database: Recent review articles by recognized experts, consensus statements, and selected primary source documents. Definitions “Adverse food reaction” is a broad term indicating a link between an ingestion of a food and an abnormal response. Reproducible adverse reactions may be caused by: a toxin, a pharmacological effect, an immunological response, or a metabolic disorder. Food allergy is a term that is used to describe adverse immune responses to foods that are mediated by IgE antibodies that bind to the triggering food protein(s); the term is also used to indicate any adverse immune response toward foods (e.g., including cell mediated reactions). -
Chapter 15 ENDOCRINE and METABOLIC IMPAIRMENT
Table of Disabilities - Chapter 15 - Endocrine and Metabolic Impairment April 2006 Chapter 15 ENDOCRINE AND METABOLIC IMPAIRMENT Introduction This chapter provides criteria used to rate permanent impairment resulting from endocrine disorders and disorders of metabolism. The endocrine system is composed of the hypothalamic-pituitary axis, the thyroid gland, the parathyroid glands, the adrenal glands, the islet cell tissue of the pancreas and the gonads. Common endocrine disorders and disorders of metabolism assessed within this chapter include: • hyperthyroidism • hypothyroidism • hyperparathyroidism • hypoparathyroidism • hyperadrenocorticism (e.g. Cushing’s disease) • hypoadrenalism (e.g. Addison’s disease) • diabetes mellitus • hyperlipidemia • metabolic bone disease (e.g. osteoporosis). Also assessed within this chapter are hypothalmic-pituitary axis disorders and Paget’s disease of the bone. The pituitary gland, influenced by the hypothalmus, releases several hormones which control the activity of other endocrine glands or directly effect tissues of the body. The hormones released include: • thyrotropin (TSH) controls activity of the thyroid gland • corticotropin (ACTH) controls the activity of the adrenal glands • luteinizing hormone (LH) and follicle-stimulating hormone (FSH) control the activity of the gonads • growth hormone (GH) • prolactin • antidiuretic hormone (ADH) • oxytocin. Veterans Affairs Canada Page 1 Table of Disabilities - Chapter 15 - Endocrine and Metabolic Impairment April 2006 Disorders of the hypothalmic-pituitary axis may affect one or several of these hormones. Each affected hormone may result in permanent impairment. Paget’s disease of the bone is a non-metabolic bone disease; however, for assessment purposes, this condition is rated by using the criteria contained within Table 15.3. A rating is not given from this chapter for conditions listed below. -
Nutrition Perspectives
Volume 44 Issue 2, March/April 2019 NutritionUniversity of California, Davis, Department ofPerspectives Nutrition and the Center for Nutrition in Schools Magnesium Helps Keep Vitamin D Levels Table of From Being Too Low or Too High Contents If some is good, more is better, right? Not always, Magnesium Helps especially when it comes to Keep Vitamin D 1 vitamin D. Vitamin D plays Levels From Being an integral role in calcium Too Low or Too High absorption and in bone health. Vitamin D deficiency has been linked to variety of Letter from diseases, including certain 2 types of cancer, multiple the Editors sclerosis cardiovascular disease, arthritis, osteoporosis, diabetes, and rickets. On the other hand, too much vitamin D can cause What is Oral toxicity, with symptoms such as GI discomfort, diarrhea, irregular 3 heartbeat, drowsiness, headaches, and muscle and joint pain. Allergy Syndome? Past studies suggest that magnesium supplementation may help maintain levels of vitamin D in the blood in the sweet spot of not too high or too low. Spicy Food May Help In order to understand how magnesium affects vitamin D in Preventing High 5 regulation, researchers at the Vanderbilt-Ingram Cancer Center Blood Pressure conducted a study to determine how magnesium supplements impact vitamin D levels in the blood. Participants (n=180) that were considered high risk Compound in Pomegranates May of developing colon cancer 7 were randomly assigned to Help Prevent Damage receive either a magnesium from IBD in Mice supplement or a placebo. Over 12 weeks, participants visited the clinic three times Fat Around the Middle May Be to provide blood samples and 8 have their height and weight Influenced by the Types of Food We Eat Magnesium continued on page 3 Volume 44 Letter from the Editors Welcome to a special UC Davis student edition of Nutrition Perspectives.